Navigation Links
USA TODAY Continues 'Spirit of the USA' Charity Program as Part of Newspaper's 25th Anniversary Celebration
Date:9/7/2007

The National Multiple Sclerosis Society highlighted today

MCLEAN, Va., Sept. 7 /PRNewswire-USNewswire/ -- As part of USA TODAY's 25th anniversary celebration, USA TODAY continues its "Spirit of the USA" 25- week charity program that highlights a different charity each week for 25 weeks.

The program began on March 30th and will continue every Friday through September 14th as USA TODAY thanks America for its support over the past 25 years by saluting the nation's generosity. USA TODAY has selected 25 charities and will celebrate the work of one charity per week for 25 weeks, both in print and online via a signature USA TODAY Snapshot as well as on a special 25th anniversary web site on http://www.USATODAY.com.

The National Multiple Sclerosis Society addresses the challenges of each person affected by MS by funding cutting-edge research, driving change through advocacy, facilitating professional education, collaborating with MS organizations around the world and providing programs and services designed to help people with multiple sclerosis and their families move their lives forward. The National Multiple Sclerosis Society are people who want to do something about MS now, and are dedicated to achieving a world free of MS.

"The members of the National Multiple Sclerosis Society and the more than one million people we serve each year are honored to be included in USA TODAY's 25th anniversary celebration," said Joyce Nelson, president and CEO of the National Multiple Sclerosis Society. "Our partnership will make great strides in building awareness about MS and in encouraging readers to become a part of the MS movement to end the disease. We thank USA TODAY for their commitment to the community and for joining the MS movement."

Readers are encouraged to learn more about the National Multiple Sclerosis Society by viewing the Snapshot on today's front page of USA TODAY and on '/>"/>

SOURCE USA TODAY
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
2. The older generation today, better off then predecessors.
3. Oral Sex and Anal Sex More Common in Teens Today
4. Minor Fire At AIIMS In The Wee Hours Today
5. New Delhi Hosting An Asian Delegation On bird Flu From Today
6. Anabolic Steroids for Today’s Young Me
7. Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign
8. Today’s Teens Slacking on Fruit, Veggie Intak
9. Today Cancer is the Deadliest Killer
10. Health Ministers Meeting on Polio Eradication Today
11. Yesteryear Bond Babe Britt Ekland is Todays Grumpy Old Woman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... WASHINGTON, Dec. 2 EIN...site providing in-depth news on breast cancer. , ...re patients are finding out that information is on... , Responding to the growing demand for accur...ors, screening procedures and drugs to treat it, E...
(Date:12/2/2008)..., A study led by researchers at The University of...e body from lung cancer. , The research, publish...demy of Sciences , USA and funded by a 72,000 gran... the tumour suppressor gene, LIMD1, is responsible...er paving the way for possible new treatments and...
(Date:12/2/2008)..., The Center for the Study of Law, Science, and T...w at Arizona State University will host an interna...iz., on the future of forensic science, with speci...he U.S. National Academy of Sciences, "Identifying..., In addition to experts from universities such a...
(Date:12/2/2008)... LONGMONT, Colo., Dec. 2 MicroPhag...oday that Lynn M. Taussig, MD has joined,the comp...nd CEO of National,Jewish Medical and Research Ce...for studying respiratory diseases, from 1993 to 20...gy. , "I have followed MicroPhage extensive...
Breaking Medicine News(10 mins):Health News:EIN News Introduces 'Breast Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:Gene which protects against lung cancer identified 2Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2
...study has found that smoking may hamper alcoholics... nine months period of alcohol abstinence . Abou... who take alcoholism treatment are chronic smokers... may interfere with the neurocognitive recovery of...
.../actress Mandy Moore admits that she doesn't mind ... The 23-year-old insisted that its part of her job...t is not a 'personal thing'. "It's not a personal...hat I have to do for my job: shape up a little bit...
...nual UN report on illegal drugs has said that opiu...rol . The World Drug Report says over 90 percent ...mes from Afghanistan. According to a BBC report,...um poppies increased dramatically in the country, ...
...people with diabetes can lose weight if they use p...tion sizes, a new study has found. The study was...lgary, Alberta, Canada led by Dr Sue D. Pedersen, ...onducted a six-month controlled trial of commercia...
Other Medicine News:Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 2Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 3Health News:Using Portion-control Dishes can Help Obese Diabetics Lose Weight 2
(Date:12/1/2008)... SINGAPORE, Dec. 1 S*BIO Pte Ltd ...ical trial of SB1518, a potent and orally-active J...alia for patients with chronic idiopathic myelofib... evaluate the safety and tolerability of SB1518 in... 50 patients. The Phase 1 part of the study will ...
(Date:12/1/2008)... Baby Girl with Hypophosphatasia Treated With ENB...re in Winnipeg , , MONTREAL, Dec. 1 /PRNews...ch company focused on developing novel therapeutic... the first infant patient in its clinical program ...ating Enzyme Replacement Therapy (ERT) with ENB-00...
(Date:12/1/2008)... , Abstinence is still the best policy , ...ire/ -- A new study from Mayo Clinic finds the use...ating alcoholic hepatitis, an acute inflammation o...ohol. The results of the study are published in th...w.gastrojournal.org/ ). , , VIDEO ALERT: A...
(Date:12/1/2008)... KVISTGARD, Denmark, December 1 /PRNewswire-F...ued in 2007 with the intent to procure an MVA-base...s and Government Services,Canada, on behalf of th...rded,a contract to Bavarian Nordic for the delive...es intend to use IMVAMUNE(R) as part of the,count...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3BioVex to Report Phase II Clinical Trial Results of OncoVEX GM CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2100 1BioVex to Report Phase II Clinical Trial Results of OncoVEX GM CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2100 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2100 3Anesiva Announces May 22 2008 Presentation at Citi Investment Research Global HealthCare Conference 19576 1New Gene Methylation Test for Prostate Cancer Available 2096 1Jazz Pharmaceuticals to Present at Investor Conferences 19573 1
...(MARKET WIRE) -- July 02, 2007 -- DOR BioPharma, I...ed today that the,first results from testing of a ...T-VACC™, have been published in the journal,... Infection and,Immunity, v. 75, p. 3043 ). These r...immunity elicited by a multivalent vaccine,that is...
... Update to Timeline for Second Pivotal Phase 3 Tri...Call/ -- Advanced Life,Sciences Holdings, Inc. , t...ficacy data from Trial CL-06, the first of two,piv...e safety and,effectiveness of cethromycin, a novel...nity acquired pneumonia (CAP). The Company,also pr...
Other Medicine Technology:DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump.
...ARE TVT is a minimally invasive, highly effective ...rinary incontinence. GYNECARE TVT is positioned cl...when needed, TVT provides tension-free support of ... takes approximately 20 to 30 minutes, with minima...
SUR-FIT® AutoLock® Urostomy Pouch with Accuseal® Tap
New Image Urostomy Pouch, Ultra-Clear
Medicine Products: